Transcatheter aortic valve implantation: Restoring the qualities of life in old age

Age and Ageing

Volumn 42, Issue 1, 2013, Pages 21-26

  Georgiadou, Panagiota ^a   Sbarouni, Eftihia ^a   Karavolias, George K ^a   Voudris, Vassilis ^a  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

Author keywords

Older people; Quality of life; Transcatheter aortic valve implantation

Indexed keywords

AORTA STENOSIS; ARTICLE; CARDIAC PATIENT; CEREBROVASCULAR DISEASE; CHRONIC LUNG DISEASE; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; ELDERLY CARE; EQ 5D; HEALTH CARE QUALITY; HEALTH STATUS; HEART VALVE REPLACEMENT; HUMAN; KANSAS CITY CARDIOMYOPATHY QUESTIONNAIRE; KIDNEY FAILURE; MINNESOTA LIVING WITH HEART FAILURE QUESTIONNAIRE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SHORT FORM 12; SHORT FORM 36; TRANSCATHETER AORTIC VALVE IMPLANTATION;

AGED; AORTIC VALVE; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; COST-BENEFIT ANALYSIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; PATIENT SELECTION; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 84871296040     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/afs110     Document Type: Article

References (30)

1. Leon MB, Smith CR, Mack M et al.; PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597-1607.
2. Ferrara N, Davia K, Abete P, Rengo F, Harding SE. Alterations in beta-adrenoceptor mechanisms in the aging heart. Relationship with heart failure. Aging (Milano) 1997; 9:391-403.
3. Iung B, Baron G, Butchart EG et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on valvular disease. Eur Heart J 2003; 24: 1231-1243.
4. Smith CR, Leon MB, Mack MJ et al.; PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011; 364:2187-2198.
5. Moat NE, Ludman P, de Belder MA et al. Long-term outcomes after transcatheter aortic valve implantation in highrisk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. J Am Coll Cardiol 2011; 58:2130-2138.
6. Ussia GP, Barbanti M, Petronio AS et al.; on behalf of the CoreValve Italian Registry Investigators. Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis. Eur Heart J 2012; 33:969-976.
7. Gurvitch R, Webb JG. Life after transcatheter aortic valve implantation: quality still matters. Heart 2010; 96:1083-1084.
8. Gotzmann M, Hehen T, Germing A et al. Short-term effects of transcatheter aortic valve implantation on neurohormonal activation, quality of life and 6-minute walk test in severe and symptomatic aortic stenosis. Heart 2010; 96: 1102-1106.
9. Krane M, Deutsch MA, Bleiziffer S et al. Quality of life among patients undergoing transcatheter aortic valve implantation. Am Heart J 2010; 160: 451-457.
10. Ussia GP, Mulè M, Barbanti M et al. Quality of life assessment after percutaneous aortic valve implantation. Eur Heart J 2009; 30: 1790-1796.
11. Bekeredjian R, Krumsdorf U, Chorianopoulos E et al. Usefulness of percutaneous aortic valve implantation to improve quality of life in patients >80 years of age. Am J Cardiol 2010; 106: 1777-1781.
12. Gonçalves A, Marcos-Alberca P, Almeria C et al. Quality of life improvement at midterm follow-up after transcatheter aortic valve implantation. Int J Cardiol 2011. [epub ahead of print].
13. Georgiadou P, Kontodima P, Sbarouni E et al. Long-term quality of life improvement after transcatheter aortic valve implantation. Am Heart J 2011;162:232-237.
14. Gotzmann M, Bojara W, Lindstaedt M et al. One-year results of transcatheter aortic valve implantation in severe symptomatic aortic valve stenosis. Am J Cardiol 2011;107:1687-1692.
15. Ussia GP, Barbanti M, Cammalleri V et al. Quality-of-life in elderly patients one year after transcatheter aortic valve implantation for severe aortic stenosis. EuroIntervention 2011; 7:573-579.
16. Reynolds MR, Magnuson EA, Lei Y et al.; for the Placement of Aortic Transcatheter Valves (PARTNER) Investigators. Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis. Circulation 2011; 124: 1964-1972.
17. Cohen DJ.; on behalf of PARTNER Investigators. Health-related quality of life after transcatheter vs. surgical aortic valve replacement in high-risk patients with severe aortic stenosis results from The PARTNER Trial (Cohort A). Transcatheter Cardiovascular Therapeutics Conference. November 7, 2011; San Francisco, USA.
18. Fairbairn TA, Meads DM, Mather AN et al. Serial change in health-related quality of life over 1 year after transcatheter aortic valve implantation: predictors of health outcomes. J Am Coll Cardiol 2012; 59: 1672-1680.
19. Krane M, Deutsch MA, Piazza N et al. One-year results of health-related quality of life among patients undergoing transcatheter aortic valve implantation. Am J Cardiol 2012; 109: 1774-1781.
20. Hickey A, Barker M, McGee H, O'Boyle C. Measuring health-related quality of life in older patient populations: a review of current approaches. Pharmacoeconomics 2005; 23: 971-993.
21. Supino PG, Borer JS, Franciosa JA et al. Acceptability and psychometric properties of the Minnesota Living With Heart Failure Questionnaire among patients undergoing heart valve surgery: validation and comparison with SF-36. J Card Fail 2009; 15: 267-277.
22. Jenkinson C, Layte R, Jenkinson D et al. A shorter form health survey: can the SF-12 replicate results from the SF-36 in longitudinal studies? J Public Health Med 1997; 19: 179-186.
23. Green CP, Porter CB, Bresnahan DR, Spertus JA. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. J Am Coll Cardiol 2000; 35: 1245-55.
24. Brooks R. EuroQol: the current state of play. Health Policy 1996; 37: 53-72.
25. Reynolds MR, Magnuson EA, Wang K et al.; PARTNER Investigators. Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the placement of aortic transcatheter valves (PARTNER) trial (Cohort B). Circulation 2012; 125: 1102-1109.
26. Watt M, Mealing S, Eaton J et al. Cost-effectiveness of transcatheter aortic valve replacement in patients ineligible for conventional aortic valve replacement. Heart 2012; 98: 370-376.
27. Neyt M, Van Brabandt H, Devriese S, Van De Sande S. A cost-utility analysis of transcatheter aortic valve implantation in Belgium: focusing on a well-defined and identifiable population. BMJ Open 2012; 2. pii: e001032.
28. Lam BK, Hendry PJ. Patients over 80 years: quality of life after aortic valve replacement. Age Ageing 2004; 33: 307-309.
29. Amonn K, Stortecky S, Brinks H et al. Quality of life in highrisk patients: comparison of transcatheter aortic valve implantation with surgical aortic valve replacement. Eur J Cardiothorac Surg 2012. [epub ahead of print].
30. Gada H, Kapadia SR, Tuzcu EM, Svensson LG, Marwick TH. Markov model for selection of aortic valve replacement versus transcatheter aortic valve implantation (without replacement) in high-risk patients. Am J Cardiol 2012; 109:1326-1333.